Please provide your email address to receive an email when new articles are posted on . “This lens looks like a multifocal, but it is not. The unique proprietary echelette design creates only one ...
Abbott announced that the Food and Drug Administration (FDA) has approved the Tecnis Symfony Intraocular Lenses for the treatment of cataracts. Abbott announced that the Food and Drug Administration ...
The Tecnis Symfony IOL is also available in four toric models, which are indicated for the reduction of residual refractive astigmatism or imperfections in the curvature of the eye. The Tecnis Symfony ...
IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...
ABBOTT PARK, Ill., June 24, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the TECNIS ® Symfony Extended Range of Vision ...
Abbott won FDA approval for the Tecnis Symfony intraocular lenses that are implanted during cataract surgeries. These are the first such lenses available in the U.S. that have a large range of focus ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved the Tecnis Symfony IOL for the treatment of cataracts, Abbott announced in a press release.
Abbott announced that the US Food and Drug Administration (FDA) has approved the Tecnis Symfony intraocular lenses for the treatment of cataracts. The first in a new category of intraocular lenses ...
The U.S. Food and Drug Administration (FDA) has approved Abbott’s Tecnis Symfony Intraocular Lenses (IOL) for treating cataracts. According to Abbott, the Tecnis Symfony lenses are currently the only ...
A long-awaited revolution in intraocular lenses (IOLs) made its Utah and Intermountain West debut in the hands of cataract surgeon, Alan S. Crandall, MD, at the University of Utah's John A. Moran Eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results